Login / Signup

Cost-effectiveness analysis of bevacizumab for cerebral radiation necrosis treatment based on real-world utility value in China.

Shaohong LuoShufei LaiYajing WuJinsheng HongDong LinShen LinXiaoting HuangXiongwei XuXiuhua Weng
Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2024)
Compared with corticosteroids, bevacizumab is an economical option for CRN treatment in China.
Keyphrases
  • subarachnoid hemorrhage
  • brain injury
  • replacement therapy
  • radiation induced
  • cerebral ischemia